Notice of Funding Opportunity (NOFO) for Cancer-Related Interventions
National Institutes of Health
Description
The grant supports research on the effects of cancer-related interventions on various cancer outcomes. It uses a two-phase approach: the first phase (UG3) focuses on refining the intervention and preparing for the study, while the second phase (UH3) involves conducting the actual trial.
This NOFO will support research that tests the impact of cancer-related interventions on cancer-related outcomes across the cancer control continuum using a pragmatic trial study design. This NOFO will use the UG3/UH3 phased cooperative agreement mechanism. The UG3 phase will support refining th…
Source
Grant ID
PAR-25-072
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Key Dates
Opportunity Released
November 18, 2024
Open for Submission
November 18, 2024
Submission Deadline
November 17, 2025
Application Window Closes
November 17, 2025
Eligibility
The following categories of applicants are invited to apply:
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofit Organizations with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofit Organizations without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Regional Organizations
- Eligible Agencies of the Federal Government
- U.S. Territories or Possessions
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
Similar opportunities
- Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
National Institutes of Health
- National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
National Institutes of Health
- Notice of Funding Opportunity (NOFO) for UG3/UH3 Phased Cooperative Agreement Research Applications
National Institutes of Health
- Facilitating Clinical Trials in Cancer Prevention and Control
National Institutes of Health
- NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12)
National Institutes of Health